| Flemming Ørnskov |
Flemming Ørnskov is currently the Chief Executive Officer at Shire Pharmaceuticals Ltd. He is also the Chief Executive Officer at Galderma Benelux BV and the Chairman & Chief Executive Officer at Galderma Holding SA. Additionally, he holds the position of Chief Executive Officer at Galderma Group AG and Independent Non-Executive Chairman at Waters Corp. Dr. Ørnskov has previously served as the President & Chief Executive Officer at Veloxis Pharmaceuticals A and Ikaria, Inc. He was also the Chief Executive Officer & Non-Executive Director at Shire Plc and Chairman, President & Chief Executive Officer at Life Cycle Pharma A. Dr. Ørnskov has a doctorate degree from Harvard University and the University of Copenhagen, as well as an MBA from INSEAD. |
